CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to address obesity by identifying patient subsets that respond safely to existing anti-obesity drugs. It focuses on discovering biomarkers and phenotypes to improve treatment efficacy and safety, particularly targeting abdominal fat.
Obesity is one of the most serious and fast-growing health problem in the European Union, and a leading cause of diabetes.
The main barrier for approval of an anti-obesity drug is the safety requirements.
We propose to overcome this barrier by discovering phenotypes and biomarkers that identify subsets of patients with safe and efficacious responses to drugs, and by identifying new indications of existing drugs with proven safety profiles.
To be approved, anti-obesity drugs need to show a decrea…
FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, TRES CANTOS MADRID
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Germany, Mainz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Bologna
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
